全国87家医院2012-2014年肿瘤患者止吐药使用情况分析

发布时间：2018-05-08 21:43

  本文选题：肿瘤 + 止吐药　； 参考：《中国药房》2017年11期

【摘要】：目的:为肿瘤患者止吐药的合理使用提供参考。方法:分别按年度、医院类型对2012-2014年"医院处方分析"项目87家参与单位的门诊、住院肿瘤患者止吐药使用相关数据进行统计分析。结果:2012-2014年87家医院共使用止吐药14种,在门诊肿瘤患者中的销售金额、使用人次分别为576.3万元、3.4万人次[平均2.2万元/(年·家)、133.1人次/(年·家)],住院肿瘤患者为6 171.1万元、51.5万人次[平均25.6万元/(年·家)、2 137.9人次/(年·家)],门诊数据小于住院数据。各年度止吐药在门诊、住院肿瘤患者所用药物中的销售金额占比为5.2‰~34.0‰,使用人次占比为2.9%~10.9%,整体使用住院患者大于门诊患者、专科医院大于综合医院;使用较多的药物为昂丹司琼、托烷司琼、甲氧氯普胺和帕洛诺司琼。结论:止吐药在肿瘤患者中应用较多,尤以5-羟色胺(5-HT3)受体拮抗药、甲氧氯普胺多用。
[Abstract]:Objective: to provide reference for the rational use of antiemetic drugs in cancer patients. Methods: the clinical data of 87 participating units of Hospital prescription Analysis Project from 2012 to 2014 were statistically analyzed according to the types of hospitals. Results there were 14 kinds of antiemetic drugs used in 87 hospitals from 2012 to 2014, and the amount of money sold in outpatient patients with cancer. The number of users was 5.763 million yuan, 34000 times [average 22000 yuan / r (annual home 133.1 person-time / year home)], 61.711 million yuan for hospitalized cancer patients, 515000 times [256000 yuan / (2,137.9 / year home)] respectively. The outpatient data were less than the in-patient data. In each year, the proportion of sales amount of drugs used in cancer patients was 5.2 鈥，

本文编号：1863195